Cargando…
High levels of SARS-CoV-2–specific T cells with restricted functionality in severe courses of COVID-19
BACKGROUND: Patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) differ in the severity of disease. We hypothesized that characteristics of SARS-CoV-2–specific immunity correlate with disease severity. METHODS: In this study, SARS-CoV-2–specific T cells and antibodies...
Autores principales: | Schub, David, Klemis, Verena, Schneitler, Sophie, Mihm, Janine, Lepper, Philipp M., Wilkens, Heinrike, Bals, Robert, Eichler, Hermann, Gärtner, Barbara C., Becker, Sören L., Sester, Urban, Sester, Martina, Schmidt, Tina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605520/ https://www.ncbi.nlm.nih.gov/pubmed/32937615 http://dx.doi.org/10.1172/jci.insight.142167 |
Ejemplares similares
-
Cellular immunity predominates over humoral immunity after homologous and heterologous mRNA and vector-based COVID-19 vaccine regimens in solid organ transplant recipients
por: Schmidt, Tina, et al.
Publicado: (2021) -
Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination
por: Schmidt, Tina, et al.
Publicado: (2021) -
Comparative immunogenicity and reactogenicity of heterologous ChAdOx1-nCoV-19-priming and BNT162b2 or mRNA-1273-boosting with homologous COVID-19 vaccine regimens
por: Klemis, Verena, et al.
Publicado: (2022) -
Is ipsilateral administration of COVID-19 vaccine boosters the optimal approach?
por: Ziegler, Laura, et al.
Publicado: (2023) -
Differences in SARS-CoV-2 specific humoral and cellular immune responses after contralateral and ipsilateral COVID-19 vaccination
por: Ziegler, Laura, et al.
Publicado: (2023)